Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.37 +0.51 (+1.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Income from Discontinued Operations (2014 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Income from Discontinued Operations of $225,498 for the quarter ended Jun 30, 2026, compared with -$1.41 million a year earlier and down 68.2% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Income from Discontinued Operations (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Income from Discontinued Operations at Lakefront Biotherapeutics was $1.62 billion, down 98.0% year-over-year; for the year ended Dec 31, 2025, it was $1.57 billion, down 98.1% from the prior year.

  • Annual Income from Discontinued Operations shows a five-year compound annual growth rate of 192.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Income from Discontinued Operations was $81.57 billion in the year ended Dec 31, 2024, $232.06 million in the year ended Dec 31, 2023, -$154.48 million in the year ended Dec 31, 2022 and $20.78 million in the year ended Dec 31, 2021 (+182.0%).
  • Quarterly Income from Discontinued Operations has run from a low of -$19.25 million in the quarter ended Sep 30, 2023 to a high of $80.46 billion in the quarter ended Dec 31, 2024 over five years.
  • According to Business Quant data, Income from Discontinued Operations for the three prior quarters was $709,472 (quarter ended Mar 31, 2026), $1.62 billion (quarter ended Dec 31, 2025) and $2.15 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Lakefront Biotherapeutics 1.94 Bn 1.94 Bn 3.51 Mn 225,498.20
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 225,498.20
Mar 31, 2026 709,471.86
Dec 31, 2025 1.62 Bn
Sep 30, 2025 2.15 Mn
Jun 30, 2025 -1.41 Mn
Mar 31, 2025 1.21 Mn
Dec 31, 2024 80.46 Bn
Sep 30, 2024 -2.04 Mn
Jun 30, 2024 4.66 Mn
Mar 31, 2024 72.48 Mn
Dec 31, 2023 212.78 Mn
Sep 30, 2023 -19.25 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 36.93 Mn
Dec 31, 2021 -5.31 Mn
Sep 30, 2021 26.18 Mn
Mar 31, 2021 26.78 Mn
Dec 31, 2020 -1.66 Mn
Sep 30, 2020 4.91 Mn
Jun 30, 2020 2.14 Mn
API Access

Lakefront Biotherapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=LKFT&period=max&api_key=YOUR_API_KEY